Oncology
ALISERPATINIB – Selpercatinib
¥27,018.00
Selpercatinib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in ret-altered cancer reference, including ret fusion-positive lung cancer and ret-altered thyroid cancer contexts within professional pharmaceutical sourcing contexts. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.
Get a Quote
For wholesale, distribution, or sourcing inquiries, please contact our team.


